UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For ~~Quarterly~~the ~~Period~~quarterly ~~Ended~~period ~~June~~ended September 30, 2020

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

~~New~~For ~~Leap,~~the ~~Inc.~~transition ~~(Exact~~period ~~name~~from of__________ to ~~registrant issuer as specified in its charter)~~__________

Commission File No. 333-219776

CHENGDA TECHNOLOGY CO., LTD.

(Exact name of registrant as specified in its charter)

Delaware		37-1863750
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

8311-7, ~~Derech~~Tianyu ~~Hameshi~~Building, ~~St.~~11 Guangming Road Dongcheng District, ~~Ganne~~Beijing, ~~Tiqwa~~China 100051 (Address of Principal Executive Offices, including zip code)

~~Israel~~+86 (10) 65014177 (Registrant’s telephone number, ~~5591179~~including area code)

Not Applicable (~~Address~~Former ofname, ~~principal~~former ~~executive~~address ~~offices~~and former fiscal year, ~~including~~if ~~zip~~changed ~~code~~since last report)

~~Registrant’s~~Securities ~~phone~~registered ~~number,~~pursuant ~~including~~to ~~area~~Section ~~code~~12(b) ~~+972-50-7844477~~ of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ~~YES~~ Yes ☒ NO No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).~~YES~~ Yes ☒ NO No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” ~~and~~ “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).: ~~YES~~ Yes ☒ NO No ☐

~~Securities~~As ~~registered~~of ~~pursuant~~November to13, ~~Section~~2020, ~~12(b)~~there were 10,204,000 shares of common stock, par value $0.0001, of the ~~Act:~~Company ~~None~~issued and outstanding.

~~Indicate~~CHENGDA ~~the~~TECHNOLOGY ~~number of shares outstanding of each of the issuer’s classes of common stock~~CO., ~~as of the latest practicable date~~LTD.

Class		Outstanding at August 7, 2020
Common Stock, $0.0001 par value		10,204,000

Quarterly Report on Form 10-Q

~~INDEX~~TABLE OF CONTENTS

			Page No.
		Page
PART I - FINANCIAL INFORMATION
Cautionary Note Regarding Forward-Looking Statements		3
ITEM 1.	FINANCIAL STATEMENTS:			3
PART I – FINANCIAL INFORMATION
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS			10
Item 1.	Financial Statements	4
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK			12
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	10
ITEM 4.	CONTROLS AND PROCEDURES			12
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	11
PART II - OTHER INFORMATION
Item 4.	Control and Procedures	11
ITEM 1.	LEGAL PROCEEDINGS			13
PART II – OTHER INFORMATION
ITEM 1A.	RISK FACTORS			13
Item 1.	Legal Proceedings	12
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS			13
Item 1A.	Risk Factors	12
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES			13
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	12
ITEM 5.	OTHER INFORMATION			13
Item 3.	Defaults Upon Senior Securities	12
ITEM 6.	EXHIBITS			14
Item 4.	Mine Safety Disclosures	12
Item 5.	Other Information	12
Item 6.	Exhibits	13
SIGNATURES		14

2 Table of Contents

~~PART~~CAUTIONARY INOTE REGARDING FORWARD-LOOKING ~~FINANCIAL INFORMATION~~ STATEMENTS

~~ITEM~~This IQuarterly —Report ~~FINANCIAL~~on ~~STATEMENTS~~Form 10-Q (the “Report”), including, without limitation, statements under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “may,” “will,” “potential,” “projects,” “predicts,” “continue,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating to our ability to consummate any acquisition or other business combination and any other statements that are not statements of current or historical facts. These statements are based on management’s current expectations, but actual results may differ materially due to various factors, including, but not limited to:

~~New~~• ~~Leap~~our ability to establish our business and implement our business plan; • acceptance of the healthcare products and services that we expect to market; • our ability to retain key employees; • adverse changes in general market conditions for the healthcare industry in China, ~~Inc~~including as a result of the COVID-19 pandemic; • our ability to continue as a going concern; • our future financing plans; and • our ability to adapt to changes in foreign, cultural, political and financial market conditions which could impair our future operations and financial performance.

~~UNAUDITED~~The ~~CONDENSED~~forward-looking ~~BALANCE~~statements ~~SHEETS~~contained in this Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

(Expressed in USD, except for the number of shares)

	June 30,		December 31,
	2020		2019
ASSETS
Current assets:
Cash and cash equivalents	$	1,368	$	1,494
Total Current assets	$	1,368	$	1,494
Total assets	$	1,368	$	1,494

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities:
Account payable to related party	$	25,000		$	25,000
Other accounts payable		1,860			5,510
Promissory note payable to shareholder		49,719			39,490
Total current liabilities	$	76,579		$	70,000
Total Liabilities	$	76,579		$	70,000
Commitments and contingencies (Note 4)
Stockholders’ Deficit:
		-			-
Common stock; $0.0001 par value, 50,000,000 shares authorized, 10,204,000 shares issued and outstanding	$	10,204		$	10,204
Addition paid-in capital		145,375			126,475
Accumulated deficit		(230,790	)		(205,185	)
Total stockholder’s deficit	$	(75,211	)	$	(68,506	)
Total liabilities and stockholders’ deficit	$	1,368		$	1,494

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

~~New~~PART ~~Leap,~~I ~~Inc.~~- FINANCIAL INFORMATION

~~UNAUDITED~~ITEM ~~CONDENSED~~1. FINANCIAL STATEMENTS ~~OF OPERATIONS AND OTHER~~.

COMPREHENSIVE INCOME (LOSS)

Chengda Technology Co., Ltd. (Formerly New Leap, Inc.) Condensed Unaudited Balance Sheets
	September 30,			December 31,
	2020			2019
ASSETS
Current Assets:
Cash	$	31		$	1,494
Total Current Assets		31			1,494
Total Assets	$	31		$	1,494
LIABILITIES AND STOCKHOLDERS' DEFICIT
Account payable to related party	$	—		$	25,000
Other accounts payable		8,100			5,510
Promissory note payable to stockholder		—			39,490
Total Current Liabilities		8,100			70,000

Total Liabilities		8,100			70,000
Stockholders’ Deficit:
Preferred stock; $0.0001 par value, 5,000,000 shares authorized, none issued and outstanding		—			—
Common stock; $0.0001 par value, 50,000,000 shares authorized, 10,204,000 shares issued and outstanding		10,204			10,204
Additional paid-in capital		227,274			126,475
Accumulated deficit		(245,547	)		(205,185	)
Total Stockholders’ Deficit		(8,069	)		(68,506	)
Total Liabilities and Stockholders’ Deficit	$	31		$	1,494

~~(Expressed~~The inaccompanying ~~USD,~~notes ~~except~~are ~~for~~an ~~the~~integral ~~number~~part of ~~shares)~~these condensed financial statements.

	Six months ended June 30,						Three months ended June 30,
	2020			2019			2020			2019
Revenues	$	-		$	-		$	-		$	-
Cost of revenues		-			-			-			-
Gross profit		-			-			-			-
Selling, General and Administrative expenses		25,605			39,078			13,291			13,820
Loss from operations		(25,605	)		(39,078	)		(13,291	)		(13,820	)
Other income, net		-			-			-			-
Loss before provision for income taxes		(25,605	)		(39,078	)		(13,291	)		(13,820	)
Income tax expense		-			-			-			-
Net Loss	$	(25,605	)	$	(39,078	)	$	(13,291	)	$	(13,820	)
Other Comprehensive loss	$	(25,605	)	$	(39,078	)	$	(13,291	)	$	(13,820	)
Loss per share
Basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Weighted average common shares outstanding:
Basic and diluted		10,204,000			10,204,000			10,204,000			10,204,000

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

~~New~~Chengda ~~Leap~~Technology Co., ~~Inc~~Ltd.

~~UNAUDITED~~(Formerly ~~CONDENSED~~New ~~STATEMENTS~~Leap, ~~OF CHANGES IN STOCKHOLDERS’ DEFICIT~~ Inc.)

~~(Expressed~~Condensed inUnaudited ~~USD,~~Statements ~~except for the number~~ of ~~shares)Six months ended June 30, 2020 and 2019~~Operations

	Common shares						Additionalpaid-in			Accumulated			Totalshareholders’
	For the Three Months Ended						For the Nine Months Ended
	Number			Amount			capital			deficit			deficit
	September 30,						September 30,
Balance as of December 31, 2018		10,204,000		$	10,204		$	88,675		$	(128,045	)	$	(29,166	)
	2020			2019			2020			2019
Shareholder contribution		-			-			18,900			-			18,900
Revenue	$	—		$	—		$	—		$	—
Net loss		-			-			-			(39,078	)		(39,078	)
Operating Expenses:
Balance as of June 30, 2019		10,204,000		$	10,204		$	107,575		$	(167,123	)	$	(49,344	)
General & administrative expenses		14,757			22,099			40,362			61,177
Total operating expenses		14,757			22,099			40,362			61,177
Loss from operations		(14,757	)		(22,099	)		(40,362	)		(61,177	)
Loss before income taxes		(14,757	)		(22,099	)		(40,362	)		(61,177	)
Provision for income taxes		—			—			—			—
Net loss	$	(14,757	)	$	(22,099	)		(40,362	)		(61,177	)
Basic & diluted net loss per share	*			*			*				(0.01	)
Weighted average number of ordinary shares-basic and diluted		10,204,000			10,204,000			10,204,000			10,204,000

	Common shares				Additionalpaid-in		Accumulated			Totalshareholders’
	Number		Amount		capital		deficit			deficit
Balance as of December 31, 2019		10,204,000	$	10,204	$	126,475	$	(205,185	)	$	(68,506	)
Shareholder contribution		-		-		18,900		-			18,900
Net loss		-		-		-		(25,605	)		(25,605	)
Balance as of June 30, 2020		10,204,000	$	10,204	$	145,375	$	(230,790	)	$	(75,211	)

* Less than $0.01

The accompanying notes are an integral part of ~~the~~these ~~unaudited~~ condensed financial statements.

Table of Contents

Chengda Technology Co., Ltd. (Formerly New Leap, Inc.) Condensed Unaudited Statements of Cash Flows

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

	For The Nine Months Ended September 30,
	2020			2019
Cash flows from operating activities:

Net loss	$	(40,362	)	$	(61,177	)
Adjustments to reconcile net loss to net cash used in operating activities:
Contributed services		24,570			28,350

Changes in assets and liabilities:
Accounts payable		2,590			(3,370	)
Net cash used in operating activities		(13,202	)		(36,197	)

Cash flows from investing activities:		—			—

Cash flows from financing activities:
Advances from related parties		10,229			16,738
Capital contributions from stockholder		1,510			—

Net cash provided by financing activities		11,739			16,738

Net decrease in cash		(1,463	)		(19,459	)

Cash, beginning of period		1,494			21,007

Cash, end of period	$	31		$	1,548

Supplemental cash flow information

Forgiveness of promissory notes by stockholder	$	49,719			—
Forgiveness of payable due to related party	$	25,000			—

Cash paid for interest expense		—			—
Cash paid for income tax		—			—

~~(Expressed~~The inaccompanying ~~USD,~~notes ~~except~~are ~~for~~an ~~the~~integral ~~number~~part of ~~shares)~~these condensed financial statements

Three months ended June 30, 2020 and 2019

	Common shares				Additionalpaid-in		Accumulated			Totalshareholders’
	Number		Amount		capital		deficit			deficit
Balance as of March 31, 2019		10,204,000	$	10,204	$	98,125	$	(153,303	)	$	(44,974	)
Shareholder contribution		-		-		9,450		-			9,450
Net loss		-		-		-		(13,820	)		(13,820	)
Balance as of June 30, 2019		10,204,000	$	10,204	$	107,575	$	(167,123	)	$	(49,344	)

	Common shares				Additionalpaid-in		Accumulated			Totalshareholders’
	Number		Amount		capital		deficit			deficit
Balance as of March 31, 2020		10,204,000	$	10,204	$	135,925	$	(217,499	)	$	(71,370	)
Shareholder contribution		-		-		9,450		-			9,450
Net loss		-		-		-		(13,291	)		(13,291	)
Balance as of June 30, 2020		10,204,000	$	10,204	$	145,375	$	(230,790	)	$	(75,211	)

The accompanying notes are an integral part of the unaudited condensed financial statements.

Table of Contents

~~New~~Chengda ~~Leap~~Technology Co., ~~Inc~~Ltd.

~~UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS~~ (~~Expressed~~Formerly inNew ~~USD~~Leap, ~~except for the number of shares~~Inc.)

	Six months endedJune 30,
	2020			2019
Cash flow from operating activities:
Net loss	$	(25,605	)	$	(39,078	)
Adjustments to reconcile net loss to net cash used in operating activities:
Contributed services		18,900			18,900
Changes in operating assets and liabilities:
Increase (decrease) in account payables		(3,650	)		(3,070	)
Net cash used in operating activities	$	(10,355	)	$	(23,248	)
Changes in investing activities	$	-		$	-
Cash flow from financing activities:
Promissory note from shareholder		10,229			3,843
Net cash provided by financing activities	$	10,229		$	3,843
NET CASH DECREASE IN CASH AND CASH EQUIVALENTS		(126	)		(19,405	)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD		1,494			21,007
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	1,368		$	1,602

Condensed Unaudited Statements of Changes in Stockholders’ Equity

~~The~~For ~~accompanying~~the ~~notes~~Nine ~~are~~Months anended ~~integral~~September ~~part~~30, ~~of the unaudited condensed financial statements.~~2020

	Common Stock
	Shares		amount		Additional paid-in capital		Accumulated Deficit			Total equity
Balance as of January 1, 2020		10,204,000	$	10,204	$	126,475	$	(205,185	)	$	(68,506	)
Net loss								(40,362	)		(40,362	)
Contributions from stockholders		-		-		26,080		-			26,080
Forgiveness of related party loan						25,000					25,000
Forgiveness of stockholder’s promissory note		-		-		49,719		-			49,719
Balance as of September 30, 2020		10,204,000	$	10,204	$	227,274	$	(245,547	)	$	(8,069	)

For the Three Months ended September 30, 2020

	Common Stock
	Shares		amount		Additional paid-in capital		Accumulated Deficit			Total equity

Balance as of July 1, 2020		10,204,000	$	10,204	$	145,375	$	(230,790	)	$	(75,211	)
Net loss								(14,757	)		(14,757	)
Contributions from stockholders		-		-		7,180		-			7,180
Forgiveness of related party loan						25,000					25,000
Forgiveness of stockholder’s promissory note		-		-		49,719		-			49,719
Balance as of September 30, 2020		10,204,000	$	10,204	$	227,274	$	(245,547	)	$	(8,069	)

For the Nine Months ended September 30, 2019

	Common Stock
	Shares		amount		Additional paid-in capital		Accumulated Deficit			Total equity
Balance as of January 1, 2019		10,204,000	$	10,204	$	88,675	$	(128,045	)	$	(29,166	)
Net loss								(61,177	)		(61,177	)
Contributions from stockholders		-		-		28,350		-			28,350
Balance as of September 30, 2019		10,204,000	$	10,204	$	117,025	$	(189,222	)	$	(61,993	)

For the Three Months ended September 30, 2019

	Common Stock
	Shares		amount		Additional paid-in capital		Accumulated Deficit			Total equity
Balance as of July 1, 2019		10,204,000	$	10,204	$	107,575	$	(167,123	)	$	(49,344	)
Net loss								(22,099	)		(22,099	)
Contributions from stockholders		-		-		9,450		-			9,450
Balance as of September 30, 2019		10,204,000	$	10,204	$	117,025	$	(189,222	)	$	(61,993	)

Table of Contents

~~New~~Chengda ~~Leap~~Technology Co., ~~Inc~~Ltd.

~~NOTES~~(Formerly TONew ~~UNAUDITED~~Leap, ~~CONDENSED FINANCIAL STATEMENTS~~Inc.)

~~(USD,~~Notes ~~except~~to ~~number~~the ofCondensed ~~shares)~~Financial Statements

~~NOTE~~September ~~1 -~~30, ~~ORGANIZATIONAL AND GOING CONCERN:~~2020

~~New~~NOTE ~~Leap, Inc. (the “Company”) was formed on June~~ 1, – ORGANIZATION ~~2017~~AND asDESCRIPTION aOF Delaware corporation. During 2017 the Company issued 9,000,000 shares of its common stock in consideration for a business plan at $0.001 per share. The Company has yet to start operational or research and development activities. The Company plans to operate in the field of crowdfunding and to run an online platform for investments in private U.S. companies and companies which are publicly traded in the U.S. (both domestic and foreign). BUSINESS

InChengda ~~January~~Technology ~~and~~Co. ~~February~~Ltd., ~~2018~~(formerly ~~the~~known ~~Company~~as ~~issued~~New ~~a total of 1~~Leap,~~204,000~~ ~~shares~~Inc.) of(the ~~its~~"Company") ~~common~~was ~~stock~~incorporated toon ~~various~~June ~~investors~~1, at2017 as a ~~price~~Delaware ~~of $0~~corporation.~~025~~ ~~per share.~~ The ~~shares~~Company ~~were~~has ~~issued~~yet ~~pursuant~~ to ~~the~~start ~~Company’s~~operational ~~registration~~or ~~statement~~research onand ~~Form~~development ~~S-1 which was declared effective by the SEC on October 20, 2017~~activities.

~~The~~On ~~accompanying~~August ~~unaudited~~12, ~~condensed~~2020, ~~financial~~pursuant ~~statements~~to ~~have~~a ~~been~~Stock ~~prepared~~Purchase ~~assuming~~Agreement ~~that~~(the “SPA”) entered into by and between Xin Jiang (the ~~Company~~“Purchaser”) ~~will~~and ~~continue~~Itzhak asOstashinsky (the “Seller”), a ~~going~~controlling ~~concern.~~stockholder ~~The~~as ~~Company~~well ~~has~~as ~~suffered~~Chief ~~cumulative~~Executive ~~losses~~Officer, Chief Financial Officer, President, Secretary and ~~negative~~director ~~cash~~of ~~flows~~the ~~from~~Company, ~~operations~~the ~~since~~Seller ~~inception~~sold to the Purchaser 8,000,000 shares of common stock, par value $0.0001 ~~Until~~per share, of the Company, ~~will~~representing ~~achieve~~78.4% ~~profitability~~of the total issued and ~~revenues,~~outstanding ~~which~~shares isof ~~uncertain~~common stock as of August 24, it2020, ~~intends~~in toconsideration ~~finance~~of ~~its~~$251,177 ~~operation~~in ~~through~~cash from the ~~issuance~~Purchaser’s ofpersonal ~~its~~funds ~~shares~~(the “Transaction”). In ~~These~~connection ~~conditions~~with ~~give~~the ~~rise~~Transaction, tothe ~~substantial~~Seller ~~doubt~~resigned ~~about~~as Chief Executive Officer, Chief Financial Officer, President, Secretary and director of the Company’s, ~~ability~~effective toimmediately ~~continue~~upon asthe aconsummation ~~going~~of ~~concern~~the Transaction. Xin ~~The~~Jiang ~~financial~~was ~~statements~~then doappointed ~~not~~as ~~include~~Chief ~~any~~Executive ~~adjustments~~Officer, ~~that~~Chief ~~may~~Financial ~~result~~Officer, ~~from~~President, Secretary and director of the ~~outcome~~Company. The Transaction resulted in a change in control of ~~this~~the ~~uncertainty~~Company.

~~NOTE~~Effective ~~2 - SUMMARY~~November OF6, ~~SIGNIFICANT~~2020, ~~ACCOUNTING~~the ~~POLICIES~~Company’s name was changed to “Chengda Technology Co., Ltd.” through the filing with the Secretary of State of the State of Delaware a Certificate of Amendment to the Certificate of Incorporation of the Company, which was approved by the Company’s Board of Directors.

After the change in control, the Company plans to implement its new business plan. The Company plans to operate in the field of health-related products, with a focus on the developing and promoting selenium-infused mineral water and energy mattress. Also, the Company plans to offer health services, including health assessments, health consultations, and health recoveries.

The Company is currently evaluating the optimal approaches to implement these plans, including through mergers and acquisitions of health companies in China. Due to the dynamic nature and the global impact of the COVID-19 pandemic, the Company cannot reasonably estimate the timeline to implement its business plan. Until the Company is able to implement its business plan, the Company will remain a shell company.

NOTE 2 – GOING CONCERN

The accompanying condensed financial statements have been prepared in conformity with United States generally accepted accounting principles (“U.S. GAAP”), which contemplate continuation of the Company as a going concern. As a start-up, the Company has not generated any revenues and has accumulated losses through September 30, 2020. The Company currently has limited working capital and does not expect to generate revenues in the near term. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

Management anticipates that the Company will be dependent, for the near future, on additional financing to fund operating expenses, primarily loans and/or capital contribution from its principal stockholder. As the Company is a shell company, its operating expenses are limited. Management believes that the financing from its principal stockholder will provide it with the funding to continue as a going concern.

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements ~~have~~reflect ~~been~~all ~~prepared~~adjustments, inconsisting ~~accordance with accounting principles generally accepted in the United States~~ of ~~America~~only ~~for~~normal ~~interim~~recurring ~~financial~~items, ~~statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission. Accordingly~~which, ~~they do not contain all information and footnotes required by accounting principles generally accepted~~ in the ~~United States of America for annual financial statements. In the~~ opinion of ~~the Company’s~~ management, ~~the~~are ~~accompanying unaudited condensed financial statements contain all the adjustments~~ necessary ~~(consisting~~for ~~only~~a offair ~~normal~~statement ~~recurring adjustments) to present the financial position~~ of the ~~Company as of June 30, 2020 and the~~ results of operations ~~and cash flows~~ for the periods ~~presented.~~shown ~~The~~and ~~results of operations for the six months ended June 30, 2020~~ are not necessarily indicative of the ~~operating~~ results to be expected for the full ~~fiscal~~ year ending December 31, 2020. These unaudited condensed financial statements should be read in conjunction with the financial statements and related notes ~~thereto~~ included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

Use of Estimates

The preparation of ~~the~~ financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of ~~assets and~~ liabilities and ~~disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and~~ expenses during the reporting ~~periods~~period. Actual results could differ from those estimates. The Company currently does not have significant estimates and assumptions.

Recent Accounting Pronouncements

~~From~~The ~~time~~Company tohas ~~time,~~reviewed the ~~FASB~~recent ~~or other standards setting bodies issue new~~ accounting pronouncements. ~~Updates~~and toconcluded ~~the~~that ~~FASB~~they ~~Accounting~~were ~~Standards~~either ~~Codifications~~not ~~(“ASC”)~~applicable ~~are~~or ~~communicated~~had ~~through~~no ~~issuance of an Accounting Standards Update. Unless otherwise discussed, we believe that the~~ impact ~~of recently issued guidance, whether adopted or~~ to ~~be adopted in~~ the ~~future,~~Company’s ~~is not expected to have a material impact on our~~ financial statements ~~upon adoption~~.

NOTE 4 – SHARE CAPITAL

There were no transactions of common stock and preferred stock during the three months and nine months ended September 30, 2020 and 2019, respectively.

The expenses incurred by the former CEO and major stockholder, Itzhak Ostashinsk, on behalf of and for the benefit of the Company, for the nine months ended September 30, 2020 and 2019 amounted to $26,080 and $28,350, respectively. These amounts were recorded as capital contributions in these periods.

Table of Contents

~~Fair~~NOTE ~~Value~~5 ~~Measurement~~– PROMISSORY NOTE PAYABLE TO A STOCKHOLDER

~~The~~Promissory notes payable represented loans advanced from the Company’s ~~discloses~~former ~~fair~~major ~~value~~stockholder ~~measurements~~to ~~for~~support ~~financial~~the ~~and~~operations ~~non-financial~~of ~~assets~~the Company. The note was interest free and ~~liabilities~~due ~~measured~~on demand. As at ~~fair~~December ~~value.~~31, ~~Fair~~2019, ~~value~~the isoutstanding ~~based~~balance onunder the ~~price~~note ~~that~~was ~~would~~$39,490. beDuring ~~received~~the tonine ~~sell~~months ended September 30, 2020, an ~~asset~~additional or$10,229 ~~paid~~was advanced from the former major stockholder to ~~transfer~~the aCompany. ~~liability~~In August 2020, in anconnection ~~orderly~~with ~~transaction~~the ~~between~~Transaction, ~~market~~the ~~participants~~former atmajor stockholder forgave the ~~measurement~~promissory ~~date.~~note payable with a cumulated balance of $49,719, which was recorded as a capital contribution to the Company.

~~The~~NOTE ~~accounting~~6 ~~standard~~– ~~establishes~~RELATED aPARTY ~~fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:~~ TRANSACTIONS

~~Level~~During 1:the ~~Quoted~~nine ~~prices~~months ~~(unadjusted)~~ended inSeptember ~~active~~30, ~~markets~~2020 ~~that~~and ~~are~~2019, ~~accessible at~~ the ~~measurement~~Company ~~date~~had ~~for assets or liabilities. The fair value hierarchy gives~~ the ~~highest~~following ~~priority~~related toparty ~~Level 1 inputs.~~ transactions:

Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data.

	·	Expense incurred by the former CEO on behalf of and for the benefit of the Company for the nine months ended September 30, 2020 and September 30, 2019 amounted to $26,080 and $28,350, respectively. The expenses incurred by the former CEO on behalf of the Company for the three months ended September 30, 2020 and 2019 were $7,180 and $9,450, respectively. These amounts were recorded as capital contributions in equity.

	·	As at December 31, 2019, the Company had a related party payable balance of $25,000 due to the son of the former major stockholder. The balance was interest free and due on demand. In August 2020, the $25,000 related party payable balance was forgiven by the related party in connection with the Transaction. Therefore, the forgiven amount was recorded as a capital contribution to the Company.

Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

NOTE 3 - PROMISSORY NOTE PAYABLE TO SHAREHOLDER

The Company has an outstanding note payable provided by the major shareholder and sole officer and director which is unsecured and bears no interest. The note is payable upon demand. The outstanding balance under the note was $49,719 and $39,490 as of June 30, 2020 and December 31, 2019, respectively.

NOTE 4 - COMMITMENTS AND CONTINGENCIES

There are no commitments or contingencies to the Company.

NOTE 5 - SHAREHOLDERS’ EQUITY

Common Stock confers upon its holders the rights to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends if declared. The Company has 50,000,000 authorized common shares. The Company also has 5,000,000 authorized preferred shares. Preferred Stock may be issued from time to time in one or more series, each of such series to have such terms as stated or expressed in the Company’s certificate of incorporation and in the resolution or resolutions providing for the issue of such series adopted by the Company’s Board of Directors. To date, no Preferred Stock has been issued. The expense incurred by the CEO and major shareholder on behalf and for the benefit of the Company for the six months ended June 30, 2020 and the year ended December 31, 2019 amounted to $18,900 and $37,800, respectively and was recorded as contribution to equity.

NOTE 6 - TRANSACTIONS WITH RELATED PARTY

A. During the period from inception (June 1, 2017) and up to the balance sheet date the CEO and major shareholder devoted to the Company approximately 10 hours per week. The expense incurred by the CEO and major shareholder on behalf and for the benefit of the Company for the six months ended June 30, 2020 and June 30, 2019 amounted to $18,900 in each period and was recorded as contribution to equity. B. A related party, who is the son of the major shareholder, provides legal advice to the Company. As of June 30, 2020 and as of December 31, 2019 the liability to him amounted to $25,000. C. The Company leases its office space from its sole officer and director at no charge. D. As of June 30, 2020 the company has an outstanding note payable to the sole officer and director.

NOTE 7 – SUBSEQUENT EVENTS

InManagement ~~accordance~~has ~~with~~evaluated ~~ASC~~subsequent ~~855-10~~events wepursuant ~~have~~to ~~analyzed~~the ~~our~~requirements ~~operations~~of ~~subsequent~~ASC toTopic ~~June 30~~855, ~~2020~~from upthe tobalance sheet date through the date ~~these~~when the financial statements were issued, and ~~have~~ determined that weno dosubsequent ~~not~~events ~~have~~occurred ~~any~~that ~~material~~would ~~subsequent~~require ~~events~~adjustment to ~~disclose~~or disclosure in ~~these~~the financial statements. ~~The Company does not expect COVID-19 to have a material effect on it.~~

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion ~~contains~~and ~~certain~~analysis ~~statements that may be deemed “forward-looking statements” within the meaning~~ of ~~the~~our ~~Private~~results ~~Securities Litigation Reform Act~~ of ~~1995.~~operations ~~Such~~and ~~statements~~financial ~~appear~~condition inshould abe ~~number~~read oftogether ~~places~~with inour ~~this~~unaudited ~~Report,~~financial ~~including,~~statements ~~without limitation, “Management’s Discussion~~ and ~~Analysis~~the ofnotes ~~Financial~~thereto, ~~Condition~~which ~~and Results of Operations.” These statements~~ are ~~not~~included ~~guarantees~~elsewhere ofin ~~future~~this ~~performance~~Report and ~~involve risks, uncertainties and requirements that are difficult to predict or are beyond~~ our ~~control.~~Annual ~~Forward-looking~~Report ~~statements speak only as of the date of this quarterly report. You should not put undue reliance~~ on ~~any~~Form ~~forward~~10-~~looking~~K ~~statements.~~for Wethe ~~assume~~year noended ~~responsibility~~December to31, ~~update~~2019 (the ~~forward-looking~~“Annual ~~statements~~Report”) ~~contained~~filed inwith ~~this quarterly report on Form 10-Q~~SEC. ~~The~~Our ~~following~~financial ~~should~~statements ~~also~~have bebeen ~~read~~prepared in ~~conjunction~~accordance with ~~the~~generally ~~unaudited~~accepted ~~Financial~~accounting ~~Statements~~principles ~~and~~in ~~notes~~the ~~thereto~~United ~~that~~States ~~appear~~(the ~~elsewhere~~“U.S. ~~in this report~~GAAP”).

~~Company~~ Overview

~~Operations~~We were in the State of Delaware incorporated on June 1, 2017. We are a development stage company and have extremely limited financial resources. We have not commenced operation nor have we established a source of equity or debt financing. Our financial statements include a note emphasizing the uncertainty of our ability to remain a going concern.

~~New~~We ~~Leap,~~plan ~~Inc.,~~to aoperate ~~Delaware~~in ~~corporation,~~the ~~(“New~~field ~~Leap”~~of ~~“Company”~~health-related ~~“we~~products,” ~~“us,”~~with ora ~~“our”)~~focus ~~was incorporated~~ on ~~June~~the 1,developing ~~2017.~~and Wepromoting ~~are~~selenium-infused amineral ~~development~~water ~~stage company~~ and ~~have~~energy ~~extremely limited financial resources~~mattress. WeIn ~~have~~addition, ~~not~~we ~~established~~plan ato ~~source~~offer ofhealth ~~equity~~services, orincluding ~~debt~~health ~~financing.~~assessments, ~~Our~~health ~~financial~~consultations, ~~statements~~and ~~include~~health ~~a note emphasizing the uncertainty of our ability to remain a going concern~~recoveries.

~~Results~~We ~~from~~are ~~Operations~~currently evaluating the optimal approaches to implement these plans, including through mergers and acquisitions of health products or services companies in China. Due to the dynamic nature and the global impact of the COVID-19 pandemic, we cannot reasonably estimate the timeline to implement our business plans.

~~Selling,~~Results ~~General~~of ~~and~~Operations ~~Administrative Expenses~~

Selling, general and administrative expenses for the six and three months ended June 30, 2020 were $25,605 and $13,291, respectively, comparing to $39,078 and $13,820 for the six and three months ended June 30, 2019, respectively. The expenses were primarily consisted of contributed services by the CEO and professional services. The Company does not expect to be materially impacted by COVID-19.Revenues

~~Liquidity~~We did not generate any revenue for the three and ~~Capital~~nine ~~Resources~~months ended September 30, 2020 and 2019 and do not expect to generate any revenue until we implement our business plan.

~~The~~General ~~following is a summary of the Company’s cash flows used in operating activities for the three months ended June 30, 2020~~ and ~~June~~Administrative ~~30, 2019:~~Expenses

	Six monthsendedJune 30,2020			Six monthsendedJune 30,2019
Net Loss	$	(25,605	)	$	(39,078	)
Net cash used in operating activities	$	(10,355	)	$	(23,248	)
Net cash provided by financing activities	$	10,229		$	3,843

During the three months ended September 30, 2020 and 2019, we incurred $14,757 and $22,099 of general and administrative expenses, respectively. During the nine months ended September 30, 2020 and 2019, we incurred $40,362 and $61,177 of general and administrative expenses, respectively. Our general and administrative expenses primarily consisted of auditor fees, officer’s contributed service costs, professional fees and filing fees, which are routine costs associated with a public company for financial reporting requirements. The decrease in the general and administrative expenses in the nine months ended September 30, 2020 compared to the same period of last year was due to one-time expenses of approximately $22,000 incurred in 2019 in connection with obtaining DTC eligibility.

10Going ~~Table of Contents~~Concern

~~Our~~The ~~resources~~future toof ~~date~~our ~~have~~company ~~been~~is ~~funds~~dependent ~~paid~~upon on our ~~behalf~~ability byto implement our ~~major~~new ~~shareholder~~business plans and ~~CEO~~initiatives and ~~funds~~our ~~raised~~ability ~~under~~to generate positive net profits from implementation of our ~~registration~~business ~~statement~~plans. Management plans to seek additional funding through either equity or debt financings from its principal stockholder to support its operations for the next twelve months. However, ~~which~~there ~~became~~is ~~effective~~no assurance that such funds will be available or available on ~~October~~acceptable 20terms. If adequate funds are not available or are not available on acceptable terms, ~~2017~~we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

AsManagement aanticipates ~~public~~that ~~entity~~the weCompany will ~~incur~~be ~~ongoing~~dependent, ~~expenses~~for ~~associated~~the ~~with~~near ~~professional fees for accounting~~future, ~~legal~~on ~~and~~additional afinancing ~~host~~to offund ~~other~~operating expenses, ~~including~~primarily ~~annual~~loans ~~reports~~ and/or ~~proxy~~capital ~~statements,~~contribution iffrom ~~required~~its principal stockholder. WeAs ~~estimate~~the ~~that~~Company ~~these~~is ~~costs~~a ~~will~~shell ~~range~~company, upits tooperating ~~$25,000~~expenses ~~per~~are ~~year~~limited. ~~over~~Management believes that the ~~next~~financing ~~few~~from ~~years~~its ~~and~~principal ~~may~~stockholder bewill ~~significantly~~provide ~~higher~~it ifwith ~~our~~the ~~business~~funding ~~volume~~to ~~and~~continue ~~transactional~~as ~~activity~~a ~~increases.~~going concern.

~~The~~Liquidity ~~Company may offer, at its discretion, shares of its common stock to settle professional fees. There can be no assurances,~~ and weCapital ~~cannot predict the likelihood, that we will be able to settle any professional fees by issuing shares of our common stock.~~Resources

AsCash ofFlows ~~June~~from ~~30,~~Operating 2020 we owed $76,579, $26,860 of which were in connection with professional services. The balance of $49,719 was owed to our major shareholder and chief executive officer for expenses incurred on behalf of the Company. There are no other significant liabilities at June 30, 2020.Activities

~~Recently~~Net ~~Issued~~cash ~~Accounting~~used ~~Pronouncements~~in operating activities was $13,202 for the nine months ended September 30, 2020, compared to net cash used in operating activities of $36,197 for the same period of 2019, represented a decrease of $22,995 in the net cash outflow in operating activities. This is due to the decrease of our net loss in nine months ended September 30, 2020 compared to the same period of 2019.

~~The~~10 ~~Company~~Table has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of ~~operations.~~Contents

~~Critical~~Cash ~~Accounting~~Flows ~~Policies~~from Financing Activities

~~The~~For ~~preparation~~the ofnine ~~financial~~months ~~statements~~ended ~~and~~September ~~related~~30, ~~notes~~2020, ~~requires~~net uscash togenerated ~~make~~by ~~judgments,~~financing ~~estimates~~activities was $11,739, representing advances and ~~assumptions~~capital ~~that~~contributions ~~affect~~from the ~~reported~~former ~~amounts~~major stockholder to support the operations of ~~assets~~the Company. For the nine months ended September 30, ~~liabilities~~2019, ~~revenue~~net ~~and~~cash ~~expenses~~generated by financing activities was $16,738, ~~and~~representing ~~related~~advances ~~disclosure~~from ofthe ~~contingent~~former ~~assets~~major ~~and~~stockholder ~~liabilities~~to support the Company’s operations.

AnCommitments ~~accounting policy is considered to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made,~~ and ifCapital ~~different estimates that reasonably could have been used, or changes in the accounting estimates that are reasonably likely to occur periodically, could materially impact the financial statements.~~Expenditures

~~Financial~~We ~~Reporting~~presently ~~Release~~have ~~No. 60 requires all companies to include a discussion of critical accounting policies or methods used in the preparation of financial statements. There are~~ no ~~critical~~material ~~policies~~commitments orfor ~~decisions~~capital ~~that rely on judgments that are based on assumptions about matters that are highly uncertain at the time the estimate is made~~expenditures. ~~Note 2 to the financial statements, included elsewhere in this report, includes a summary of the significant accounting policies and methods used in the preparation of our financial statements.~~

~~Going~~Critical ~~Concern~~Accounting Policies Involving Management Estimates and Assumptions

AsOur ~~reflected~~discussion inand ~~the~~analysis ~~condensed~~of our financial condition and results of operations is based on our financial statements,. ~~the~~In ~~Company~~preparing ~~has~~our ~~incurred~~financial ~~significant~~statements ~~current~~in ~~period~~conformity ~~losses~~with U.S. GAAP, ~~negative~~we ~~cash~~must ~~flows~~make ~~from~~a ~~operating~~variety ~~activities,~~of ~~has~~estimates ~~negative~~that ~~working~~affect ~~capital,~~the ~~and~~reported anamounts ~~accumulated~~and ~~deficit~~related disclosures. ~~These~~See ~~conditions,~~Note ~~among~~3 ~~others,~~of ~~raise~~our ~~substantial~~interim ~~doubt~~financial ~~about~~statements included elsewhere in this Report and the Company’s ~~ability~~Annual toReport ~~continue~~on asForm a10-K ~~going~~for ~~concern~~the ~~even~~year ifended weDecember ~~keep~~31, ~~costs to a minimum~~2019.

11Off-Balance ~~Table~~Sheet ~~of Contents~~Arrangements

~~Off~~We do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-~~Balance~~balance ~~Sheet~~sheet ~~Arrangements~~financial arrangements.

WeITEM ~~have~~3. QUANTITATIVE ~~not~~AND ~~entered~~QUALITATIVE ~~into~~DISCLOSURES ~~any~~ABOUT ~~off-balance~~MARKET sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors. RISK

~~Contractual~~Not ~~Obligations~~applicable.

AsITEM ~~a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide this information~~4. CONTROLS AND PROCEDURES

~~ITEM~~Disclosure 3controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. ~~QUANTITATIVE~~Disclosure ~~AND~~controls ~~QUALITATIVE~~and ~~DISCLOSURES~~procedures ~~ABOUT~~include, ~~MARKET~~without ~~RISK~~limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

As arequired ~~“smaller~~by ~~reporting~~Rules ~~company”~~13a-15 and 15d-15 under the Exchange Act, our principal executive officer and principal financial officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2020. Based upon their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures (as defined byin ~~Item~~Rules 1013a-15 of(e) ~~Regulation~~and S15d-K,15 (e) under the ~~Company~~Exchange isAct) were not ~~required~~effective due to ~~provide~~the ~~information~~following ~~required~~material byweaknesses, ~~this~~which ~~Item~~are indicative of many small companies with limited resources: (i) lack of proper segregation of duties and risk assessment process; (ii) lack of formal documentation in internal controls over financial reporting; and (iii) lack of independent directors and an audit committee.

~~ITEM~~Changes 4.in ~~CONTROLS~~Internal ~~AND~~Control ~~PROCEDURES.~~over Financial Reporting

~~Evaluation~~There ofwere ~~Disclosure~~no ~~Controls~~changes ~~and~~in ~~Procedures~~the Company’s internal control over financial reporting during the quarter ended September 30, 2020 that have materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

We11 ~~conducted~~Table ~~an evaluation under the supervision and with the participation~~ of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. The term “disclosure controls and procedures”, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (“Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC`s rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.Contents

~~Based~~PART onII ~~this~~- ~~evaluation,~~OTHER our Chief Executive Officer and Chief Financial Officer concluded as of June 30, 2020, that our disclosure controls and procedures are not effective at a reasonable assurance level and are designed to provide reasonable assurance that the controls and procedures will meet their objectives due to the material weaknesses described below. However, it should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.INFORMATION

~~Changes~~ITEM in1. LEGAL ~~Internal Control over Financial Reporting~~PROCEEDINGS.

There were no changes in the Company’s internal control over financial reporting that occurred since December 31, 2019 that have materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reportingNone.

12ITEM ~~Table~~1A. RISK ~~of Contents~~FACTORS.

~~PART~~Not ~~II -- OTHER INFORMATION~~applicable

~~Item~~ITEM 12. UNREGISTERED ~~Legal~~SALES ~~Proceedings~~OF EQUITY SECURITIES AND USE OF PROCEEDS.

~~To the best of our knowledge, the Company is not a party to any legal proceeding or litigation~~None.

~~Item~~ITEM 1A3. DEFAULTS ~~Risk~~UPON ~~Factors~~SENIOR SECURITIES.

~~As a “smaller reporting company”, we are not required to provide the information required by this Item~~None.

~~Item~~ITEM 24. MINE ~~Unregistered~~SAFETY ~~Sales of Equity Securities and Use of Proceeds~~DISCLOSURES.

~~There~~Not ~~were no sales of unregistered equity securities during the period covered by this report on Form 10-Q~~applicable. Our registration statement on Form S-1, file number 333-219776, became effective on October 20, 2017 and then again on June 12, 2019 following the filing of a post-effective amendment to the registration statement. The offering pursuant to this registration statement was terminated on April 20, 2018. Proceeds raised in the offering are used for general expenses.

~~Item~~ITEM 35. OTHER ~~Defaults upon Senior Securities~~INFORMATION.

None.

~~Item~~12 5.Table ~~Other~~of ~~Information.~~Contents

~~None.~~ITEM 6. EXHIBITS.

13The ~~Table~~following exhibits are filed as part of, ~~Contents~~or incorporated by reference into, this Quarterly Report.

Item 6. Exhibits.

No.		Description of Exhibit
3.1*		Certificate of Amendment to Certificate of Incorporation, incorporated herein by reference Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on November 6, 2020.
31.1*		Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		XBRL Instance Document
101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*		XBRL Taxonomy Extension Schema Document
101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

31		Certification of President pursuant to Exchange Act Rule 13a-14 and 15d-14.
32		Certification of the Company’s Chief Executive Officer and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

*Filed herewith

101.INS **		XBRL Instance Document
101.SCH **		XBRL Taxonomy Extension Schema Document
101.CAL **		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF **		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB **		XBRL Taxonomy Extension Label Linkbase Document
101.PRE **		XBRL Taxonomy Extension Presentation Linkbase Document

**Furnished herewith

~~___________~~13 Table of Contents

** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections. SIGNATURES

14Pursuant ~~Table~~to the requirements of ~~Contents~~Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SIGNATURES

		CHENGDA TECHNOLOGY CO., LTD.

Date: November 13, 2020	By:	/s/ Xin Jiang
	Name:	Xin Jiang
	Title:	Chief Executive Officer, Chief Financial Officer and President
		(Principal Executive Officer and Principal Financial and Accounting Officer)

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.~~ 14

	NEW LEAP, INC.
Date: August 7, 2020	By:	/s/ Itzhak Ostashinsky
		Itzhak Ostashinsky
		Chief Executive Officer, President and Chief Financial Officer

Filing Compare · Chengda Technology Co., Ltd.